InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

NovoCure Ltd

NVCR Clue Score34
Fiscal year ends December CIK 0001645113 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

47
Insider
Date
Role
Action
Shares
Price
Amount
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
7,183
$120.00
$861.96K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
7,183
$114.00
$818.86K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
5,517
$108.00
$595.84K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
7,500
$108.00
$810.00K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
7,826
$108.00
$845.21K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
1,010
$117.00
$118.17K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
526
$115.03
$60.51K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
417
$108.00
$45.04K
Frank X Leonard
5 Jan 2023
President, CNS Cancers US
Sold after exercise
2,345
$119.01
$279.07K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
187,500
$108.00
$20.25M
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
500
$119.99
$59.99K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
1,344
$119.35
$160.41K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
2,123
$118.47
$251.51K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
999
$117.01
$116.89K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
1,395
$116.06
$161.91K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
3,702
$115.21
$426.51K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
4,568
$114.35
$522.36K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
2,000
$112.86
$225.73K
Asaf Danziger
5 Jan 2023
Chief Executive Officer
Sold after exercise
8,369
$111.23
$930.92K
Uri Weinberg
5 Jan 2023
Chief Science Officer
Sold after exercise
1,201
$120.00
$144.12K
Uri Weinberg
5 Jan 2023
Chief Science Officer
Sold after exercise
2,617
$108.00
$282.64K
Uri Weinberg
5 Jan 2023
Chief Science Officer
Sold after exercise
1,946
$120.00
$233.52K
Uri Weinberg
5 Jan 2023
Chief Science Officer
Sold after exercise
2,379
$120.00
$285.48K
Frank X Leonard
15 Sep 2022
Chief Development Officer
Sold after exercise
5,517
$90.00
$496.53K
Frank X Leonard
15 Sep 2022
Chief Development Officer
Sold after exercise
6,754
$87.31
$589.69K
William Patrick Burke
3 Jan 2022
Chief Human Resources Officer
Sold after exercise
399
$76.03
$30.34K
William Patrick Burke
3 Jan 2022
Chief Human Resources Officer
Sold after exercise
919
$76.09
$69.92K
William Patrick Burke
3 Jan 2022
Chief Human Resources Officer
Sold after exercise
2,633
$75.96
$200.00K
Ashley Cordova
12 Aug 2021
Chief Financial Officer
Sold after exercise
2,606
$140.90
$367.19K
Ashley Cordova
12 Aug 2021
Chief Financial Officer
Sold after exercise
7,298
$140.90
$1.03M
Ashley Cordova
12 Aug 2021
Chief Financial Officer
Sold after exercise
2,767
$140.90
$389.87K
Ashley Cordova
12 Aug 2021
Chief Financial Officer
Sold after exercise
8,026
$140.90
$1.13M
Ashley Cordova
12 Aug 2021
Chief Financial Officer
Sold after exercise
5,927
$141.06
$836.06K
Gabriel Leung
5 Aug 2021
Director
Sold after exercise
1,000
$152.50
$152.50K
Ely Benaim
30 Jul 2021
Chief Medical Officer
Sold after exercise
651
$158.96
$103.48K
Gabriel Leung
6 Jul 2021
Director
Sold after exercise
1,000
$183.54
$183.54K
Gabriel Leung
7 Jun 2021
Director
Sold after exercise
1,000
$204.55
$204.55K
Ely Benaim
27 May 2021
Chief Medical Officer
Sold after exercise
1,833
$200.00
$366.60K
Uri Weinberg
10 May 2021
Chief Science Officer
Sold after exercise
1,804
$189.65
$342.13K
Uri Weinberg
10 May 2021
Chief Science Officer
Sold after exercise
3,846
$189.65
$729.39K
Ely Benaim
10 May 2021
Chief Medical Officer
Sold after exercise
1,833
$189.65
$347.63K
Gabriel Leung
5 May 2021
Director
Sold after exercise
1,000
$199.67
$199.67K
Ely Benaim
13 Apr 2021
Chief Medical Officer
Sold after exercise
3,474
$200.00
$694.80K
Ely Benaim
13 Apr 2021
Chief Medical Officer
Sold after exercise
651
$200.00
$130.20K
Ely Benaim
13 Apr 2021
Chief Medical Officer
Sold after exercise
1,833
$200.00
$366.60K
Gabriel Leung
13 Apr 2021
Director
Sold after exercise
2,500
$200.00
$500.00K
Gabriel Leung
13 Apr 2021
Director
Sold after exercise
3,500
$198.01
$693.04K
Showing 250 of 970 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 688
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 414
Sales at will 468
Transactions with no price 2
Shares from compensation/vesting 43,129,995
Sales filed before the plan box existed 394
History held since 5 Oct 2015